Ijeoma Edoka to Cost-Benefit Analysis
This is a "connection" page, showing publications Ijeoma Edoka has written about Cost-Benefit Analysis.
Connection Strength
2,052
-
Estimating a cost-effectiveness threshold for health care decision-making in South Africa. Health Policy Plan. 2020 Jun 01; 35(5):546-555.
Score: 0,615
-
Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa. Value Health Reg Issues. 2019 Sep; 19:65-74.
Score: 0,572
-
Response to a commentary by Barr (2022) on Edoka and Stacey (2020) estimating a cost-effectiveness threshold for healthcare decision-making in South Africa. Health Policy Plan. 2022 Sep 13; 37(8):1070-1073.
Score: 0,180
-
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme. Vaccine. 2021 01 08; 39(2):412-422.
Score: 0,159
-
Strengthening expertise for health technology assessment and priority-setting in Africa. Glob Health Action. 2017; 10(1):1370194.
Score: 0,121
-
Cost-effectiveness of community-based practitioner programmes in Ethiopia, Indonesia and Kenya. Bull World Health Organ. 2015 Sep 01; 93(9):631-639A.
Score: 0,110
-
Healthcare costs of paternal depression in the postnatal period. J Affect Disord. 2011 Sep; 133(1-2):356-60.
Score: 0,082
-
Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa. Health Policy Plan. 2024 Mar 12; 39(3):253-267.
Score: 0,050
-
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries. Appl Health Econ Health Policy. 2022 05; 20(3):337-349.
Score: 0,043
-
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates. Pharmacoeconomics. 2022 01; 40(1):31-43.
Score: 0,042
-
Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
Score: 0,039
-
Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
Score: 0,038